<DOC>
	<DOCNO>NCT02380209</DOCNO>
	<brief_summary>Evaluate feasibility translate preclinical Chemical Exchange Saturation Transfer ( CEST ) MRI protocol design estimate tumor extracellular pH ( pHe ) clinical MRI scanner woman early stage breast cancer . Assays use quantify tumor acidosis .</brief_summary>
	<brief_title>An Early Phase Clinical Trial Evaluate Feasibility CEST MRI Patients With Early Stage Breast Cancer</brief_title>
	<detailed_description>Those involved treatment patient breast cancer pioneer field personalized cancer therapy use target therapy associate biomarkers . Assays quantify tumor acidosis hypoxia hypothesize potentially represent biomarkers . However currently gold standard measure either . This trial evaluate feasibility translate preclinical Chemical Exchange Saturation Transfer ( CEST ) MRI protocol design estimate tumor extracellular pH ( pHe ) , clinical MRI scanner woman early stage breast cancer . This trial generate preliminary data regard feasibility imaging technique . If successful , future study CEST MRI may serve image biomarker acidosis hypoxia .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Newly diagnose infiltrate ductal carcinoma ( IDC ) breast &gt; = 1.0 cm primary tumor Calculated creatinine clearance &gt; = 50 mL/min Willing able provide inform consent Age â‰¥ 18 year ECOG performance status 02 Informed investigational nature study Allergy iodinate contrast agent Use metformin , aminoglycosides , nephrotoxic medication , daily use NSAIDs Diabetes mellitus History severe claustrophobia Presence electrically , magnetically , mechanically activated implant include cardiac pacemaker , cochlear implant , magnetic surgical clip prosthesis would preclude MRI Use &gt; 1 antihypertensive drug Pregnancy breastfeed Paraproteinemia syndrome multiple myeloma Collagen vascular disease Active hyperthyroidism Active pharmaceutical treatment cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>CEST MRI</keyword>
</DOC>